Peramivir (RAPIVAB (peramivir injection)
Award Notice Posted
A later notice was posted: the Limited / Sole Source Justification from .
- Solicitation number
- 75A50324F80012
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Biocryst Pharmaceuticals Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79721D0166-75A50324F80012 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Durham, North Carolina 27703, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice is for the supply of Peramivir (RAPIVAB (peramivir injection) 200mg/20ml vial (10mg/ml inj soln) by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The contract was awarded to BIOCRYST PHARMACEUTICALS INC on September 25, 2024 for $69,388,368.75. The Award Notice does not specify the quantity of goods to be provided under the contract.
Notice text
This requirement is for the supply of Peramivir (RAPIVAB (peramivir injection) 200mg/20ml vial (10mg/ml inj soln).
Awarded contract 36F79721D0166 to BIOCRYST PHARMACEUTICALS INC for 69388368.75 on 2024-09-25.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Peramivir (RAPIVAB (peramivir injection) | Limited / Sole Source Justification | |
| This notice | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity